1305 related articles for article (PubMed ID: 24703908)
1. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
2. Angiography reveals novel features of the retinal vasculature in healthy and diabetic mice.
McLenachan S; Magno AL; Ramos D; Catita J; McMenamin PG; Chen FK; Rakoczy EP; Ruberte J
Exp Eye Res; 2015 Sep; 138():6-21. PubMed ID: 26122048
[TBL] [Abstract][Full Text] [Related]
3. Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.
Wisniewska-Kruk J; van der Wijk AE; van Veen HA; Gorgels TG; Vogels IM; Versteeg D; Van Noorden CJ; Schlingemann RO; Klaassen I
Am J Pathol; 2016 Apr; 186(4):1044-54. PubMed ID: 26878208
[TBL] [Abstract][Full Text] [Related]
4. Retinal VEGF-A Overexpression Is Not Sufficient to Induce Lymphangiogenesis Regardless of VEGF-C Upregulation and Lyve1+ Macrophage Infiltration.
Wada I; Nakao S; Yamaguchi M; Kaizu Y; Arima M; Sawa S; Sonoda KH
Invest Ophthalmol Vis Sci; 2021 Oct; 62(13):17. PubMed ID: 34673901
[TBL] [Abstract][Full Text] [Related]
5. The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy.
Chaurasia SS; Lim RR; Parikh BH; Wey YS; Tun BB; Wong TY; Luu CD; Agrawal R; Ghosh A; Mortellaro A; Rackoczy E; Mohan RR; Barathi VA
Sci Rep; 2018 Feb; 8(1):2847. PubMed ID: 29434227
[TBL] [Abstract][Full Text] [Related]
6. Endothelial Cell-Specific Inactivation of TSPAN12 (Tetraspanin 12) Reveals Pathological Consequences of Barrier Defects in an Otherwise Intact Vasculature.
Zhang C; Lai MB; Pedler MG; Johnson V; Adams RH; Petrash JM; Chen Z; Junge HJ
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2691-2705. PubMed ID: 30354230
[TBL] [Abstract][Full Text] [Related]
7. The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema.
Bosma EK; van Noorden CJF; Schlingemann RO; Klaassen I
Fluids Barriers CNS; 2018 Sep; 15(1):24. PubMed ID: 30231925
[TBL] [Abstract][Full Text] [Related]
8. In vivo monitoring of VEGF-induced retinal damage in the Kimba mouse model of retinal neovascularization.
Ali Rahman IS; Li CR; Lai CM; Rakoczy EP
Curr Eye Res; 2011 Jul; 36(7):654-62. PubMed ID: 21657827
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a mouse model of hyperglycemia and retinal neovascularization.
Rakoczy EP; Ali Rahman IS; Binz N; Li CR; Vagaja NN; de Pinho M; Lai CM
Am J Pathol; 2010 Nov; 177(5):2659-70. PubMed ID: 20829433
[TBL] [Abstract][Full Text] [Related]
10. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
11. Dietary Compound Chrysin Inhibits Retinal Neovascularization with Abnormal Capillaries in db/db Mice.
Kang MK; Park SH; Kim YH; Lee EJ; Antika LD; Kim DY; Choi YJ; Kang YH
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27918469
[TBL] [Abstract][Full Text] [Related]
12. Retinal angiogenesis in the Ins2(Akita) mouse model of diabetic retinopathy.
Han Z; Guo J; Conley SM; Naash MI
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):574-84. PubMed ID: 23221078
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.
Klaassen I; Van Noorden CJ; Schlingemann RO
Prog Retin Eye Res; 2013 May; 34():19-48. PubMed ID: 23416119
[TBL] [Abstract][Full Text] [Related]
14. Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model.
Shen WY; Lai CM; Graham CE; Binz N; Lai YK; Eade J; Guidolin D; Ribatti D; Dunlop SA; Rakoczy PE
Diabetologia; 2006 Jul; 49(7):1690-701. PubMed ID: 16752188
[TBL] [Abstract][Full Text] [Related]
15. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization.
van Eeden PE; Tee LB; Lukehurst S; Lai CM; Rakoczy EP; Beazley LD; Dunlop SA
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4638-45. PubMed ID: 17003462
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of trophic factors contributes to diabetic retinopathy in the Ins2
Araújo RS; Silva MS; Santos DF; Silva GA
Exp Eye Res; 2020 May; 194():108027. PubMed ID: 32259534
[TBL] [Abstract][Full Text] [Related]
17. VEGF164 is proinflammatory in the diabetic retina.
Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
[TBL] [Abstract][Full Text] [Related]
18. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomics analysis of pericytes from retinas of diabetic animals reveals novel genes and molecular pathways relevant to blood-retinal barrier alterations in diabetic retinopathy.
Rangasamy S; Monickaraj F; Legendre C; Cabrera AP; Llaci L; Bilagody C; McGuire P; Das A
Exp Eye Res; 2020 Jun; 195():108043. PubMed ID: 32376470
[TBL] [Abstract][Full Text] [Related]
20. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis.
Huang H; Gandhi JK; Zhong X; Wei Y; Gong J; Duh EJ; Vinores SA
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1336-44. PubMed ID: 21212173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
